UNSPSC 51333707: Prothipendyl hydrochloride

This classification denotes an antipsychotic agent with the molecular formula C16H19N3S.ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7610629RVH, chemically known as 10h-pyrido(3,2-b)(1,4)benzothiazine, 10-(3-(dimethylamino)propyl)-, monohydrochloride but more generally known as prothipendyl hydrochloride, which bears US NIH Compound Identifier 14669. European Medicines Agency schedules Prothipendyl hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04111MIG.

UNSPSC 51333707 Prothipendyl hydrochloride is a Commodity code that records pharmaceutical procurement activity, though recent state and local solicitations tagged under this code do not align with the pharmaceutical name specified. The single recent opportunity in the database shows Seminole County, Florida issuing an IFB for naloxone and drug deactivation systems—products unrelated to prothipendyl hydrochloride. This mismatch suggests either a cataloging error in the source data or that the code is not actively used to classify relevant pharmaceutical procurement. The issuing body is a county health department sourcing public-health supplies through competitive bidding. No evidence of repeat buyers or activity from other jurisdictions appears in the available records.

Seminole County's July 2023 IFB (IFB60459723LAS) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually for the Seminole County Community Health Building in Sanford, Florida, with quarterly deliveries and a two-year initial term plus one-year renewal option. The procurement required electronic bid submission, E-Verify compliance, drug-free workplace certification, and specific insurance coverage. The code shows minimal recent activity; no other state or local opportunities appear in the dataset under this Commodity code, and the single solicitation present is unrelated to prothipendyl hydrochloride as named.